NASDAQ:XBIO

Xenetic Biosciences Shares Edge Down Ahead of ASCO Update
····

Xenetic Biosciences Shares Edge Down Ahead of ASCO Update

Xenetic Biosciences shares slipped 4 cents to $2.90 in thin early Nasdaq trading Friday, with only 144 shares changing hands. The company holds $7.3 million in cash and is set to present cancer drug research at an ASCO poster session on June 1. Xenetic is still considering strategic alternatives. First-quarter royalty revenue rose 36% to $807,000, while net loss narrowed to $456,000.
May 22, 2026

Stock Market Today

  • Guzman Y Gomez Shares Plunge 37% but Show Strong Growth Prospects
    May 29, 2026, 9:18 PM EDT. Guzman Y Gomez Ltd (ASX: GYG), an Australian Mexican restaurant chain, has seen its shares fall over 37% in the past year and more than 55% since December 2024. Despite the volatility, the company has ambitious growth plans, aiming to expand its Australian restaurant count from 242 to 1,000 within 20 years. It reported 20% network sales growth and 6.6% comparable sales growth in Australia in Q3 FY26, with underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) expected to rise 29% year-on-year to about AUD 85 million. Asian operations, particularly in Japan and Singapore, are growing at 15% per year but remain a small portion of total sales. Rising profit margins could further boost future earnings, making GYG a notable opportunity outside the volatile tech sector.